China Shineway Pharmaceutical Group (China Shineway Pharmaceutical Group) Long-Term Capital Lease Obligation : $0.1 Mil (As of Dec. 2023)

View and export this data going back to 2008. Start your Free Trial

What is China Shineway Pharmaceutical Group Long-Term Capital Lease Obligation?

China Shineway Pharmaceutical Group's Long-Term Capital Lease Obligation for the quarter that ended in Dec. 2023 was $0.1 Mil.

China Shineway Pharmaceutical Group's quarterly Long-Term Capital Lease Obligation declined from Dec. 2022 ($0.1 Mil) to Jun. 2023 ($0.1 Mil) and declined from Jun. 2023 ($0.1 Mil) to Dec. 2023 ($0.1 Mil).

China Shineway Pharmaceutical Group's annual Long-Term Capital Lease Obligation declined from Dec. 2021 ($1.2 Mil) to Dec. 2022 ($0.1 Mil) and declined from Dec. 2022 ($0.1 Mil) to Dec. 2023 ($0.1 Mil).

China Shineway Pharmaceutical Group Long-Term Capital Lease Obligation Historical Data

The historical data trend for China Shineway Pharmaceutical Group's Long-Term Capital Lease Obligation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

China Shineway Pharmaceutical Group Long-Term Capital Lease Obligation Chart

China Shineway Pharmaceutical Group Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Long-Term Capital Lease Obligation

Get a 7-Day Free Trial

0.21

2.30

1.15

0.13

0.05

China Shineway Pharmaceutical Group Semi-Annual Data
	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Long-Term Capital Lease Obligation	Get a 7-Day Free Trial															1.15	0.57	0.13	0.09	0.05

China Shineway Pharmaceutical Group (OTCPK:CSWYY) Long-Term Capital Lease Obligation Explanation

Long-Term Capital Lease Obligation are the amount due for long-term asset lease agreements that are nearly equivalent to asset purchases. Capital lease obligations are installment payments that constitute a payment of principal plus interest for the capital lease. The Short-Term Capital Lease Obligation is the portion of a Long-Term Capital Lease Obligation that is due over the next year.

Under US Generally Accepted Accounting Principles (GAAP), a capital lease is essentially equivalent to a purchase by the lessee if it meets the following criteria:

1. Ownership of the asset is transferred to the lessee at the end of the lease term;
2. The lease contains a bargain purchase option to buy the equipment at less than fair market value;
3. The lease term equals or exceeds 75% of the asset's estimated useful life;
4. The present value of the lease payments equals or exceeds 90% of the total original cost of the equipment.

China Shineway Pharmaceutical Group Long-Term Capital Lease Obligation Related Terms

Thank you for viewing the detailed overview of China Shineway Pharmaceutical Group's Long-Term Capital Lease Obligation provided by GuruFocus.com. Please click on the following links to see related term pages.

China Shineway Pharmaceutical Group (China Shineway Pharmaceutical Group) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » China Shineway Pharmaceutical Group Ltd (OTCPK:CSWYY) » Definitions » Long-Term Capital Lease Obligation

Comparable Companies

Traded in Other Exchanges

02877:Hong Kong C1S:Germany

Address

Luan Cheng, Hebei Province, Shijiazhuang, CHN

Website

http://www.shineway.com.hk

China Shineway Pharmaceutical Group Ltd is an investment holding company in the People's Republic of China. Principally, it is engaged in the research, development, manufacturing, and trading of modern Chinese medicines. The company's products comprise injection, soft capsule, granule, and others of which injection generates maximum revenue to the company.

China Shineway Pharmaceutical Group (China Shineway Pharmaceutical Group) Headlines

From GuruFocus

China Shineway Pharmaceutical Group Ltd (CSWYF): A Deep Dive into its Dividend Performance

By GuruFocus Research • 09-12-2023